China SXT Pharmaceuticals (SXTC) Current Taxes: 2018-2025
- China SXT Pharmaceuticals' Current Taxes fell 5.17% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 5.17%. This contributed to the annual value of $1.0 million for FY2025, which is 2.00% down from last year.
- Latest data reveals that China SXT Pharmaceuticals reported Current Taxes of $1.0 million as of Q3 2025, which was up 0.64% from $1.0 million recorded in Q1 2025.
- In the past 5 years, China SXT Pharmaceuticals' Current Taxes registered a high of $1.2 million during Q3 2021, and its lowest value of $1.0 million during Q1 2025.
- Its 3-year average for Current Taxes is $1.1 million, with a median of $1.1 million in 2024.
- In the last 5 years, China SXT Pharmaceuticals' Current Taxes soared by 317.93% in 2021 and then declined by 5.38% in 2023.
- Over the past 5 years, China SXT Pharmaceuticals' Current Taxes (Quarterly) stood at $1.2 million in 2021, then rose by 0.56% to $1.2 million in 2022, then decreased by 5.38% to $1.1 million in 2023, then declined by 4.74% to $1.1 million in 2024, then dropped by 5.17% to $1.0 million in 2025.
- Its Current Taxes stands at $1.0 million for Q3 2025, versus $1.0 million for Q1 2025 and $1.1 million for Q3 2024.
